Back to search results

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

Israel
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Generalized Myasthenia Gravis

Locations
  • Honor Health Research Institute, Scottsdale, Arizona, United States
  • Fullerton Neuro and Headache Ctr, Fullerton, California, United States
  • SC3 Research Pasadena, Pasadena, California, United States
  • California Pacific Medical Center, Sacramento, California, United States
  • Neurology Offices Of South Florida, Boca Raton, Florida, United States
  • Superior Associates in Research LLC, Hialeah, Florida, United States
  • Augusta University Georgia, Augusta, Georgia, United States
  • Hawaii Pacific Neuroscience LLC, Honolulu, Hawaii, United States
  • University of Chicago Medical Centr, Chicago, Illinois, United States
  • Prairie Heart Institute, Springfield, Illinois, United States
  • Mid Atlantic Epilepsy and Sleep Ctr, Bethesda, Maryland, United States
  • Duke University Medical Center, Durham, North Carolina, United States
  • Neuroscience Research Ctr, Canton, Ohio, United States
  • Ohio State University Medical Center, Columbus, Ohio, United States
  • Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
  • Vanderbilt University Medical CenterX, Nashville, Tennessee, United States
  • Nerve and Muscle Center of Texas, Houston, Texas, United States
  • Central TX Neuro Consultants P A, Round Rock, Texas, United States
  • Center for Neurological Disorders G, Greenfield, Wisconsin, United States
  • Novartis Investigative Site, Buenos Aires, Argentina
  • Novartis Investigative Site, São Paulo, Brazil
  • Novartis Investigative Site, Hefei, Anhui, China
  • Novartis Investigative Site, Guangzhou, Guangdong, China
  • Novartis Investigative Site, Shenzhen, Guangdong, China
  • Novartis Investigative Site, Shijiazhuang, Hebei, China
  • Novartis Investigative Site, Changsha, Hunan, China
  • Novartis Investigative Site, Suzhou, Jiangsu, China
  • Novartis Investigative Site, Nanchang, Jiangxi, China
  • Novartis Investigative Site, Xi'an, Shaanxi, China
  • Novartis Investigative Site, Xianyang, Shaanxi, China
  • Novartis Investigative Site, Beijing, China
  • Novartis Investigative Site, Beijing, China
  • Novartis Investigative Site, Beijing, China
  • Novartis Investigative Site, Fujian, China
  • Novartis Investigative Site, Jinan, China
  • Novartis Investigative Site, Copenhagen, Denmark
  • Novartis Investigative Site, Limoges, Haute Vienne, France
  • Novartis Investigative Site, Garches, France
  • Novartis Investigative Site, Nice, France
  • Novartis Investigative Site, Paris, France
  • Novartis Investigative Site, Paris, France
  • Novartis Investigative Site, Würzburg, Bavaria, Germany
  • Novartis Investigative Site, Frankfurt am Main, Hesse, Germany
  • Novartis Investigative Site, Bochum, Germany
  • Novartis Investigative Site, Athens, Greece
  • Novartis Investigative Site, Chaïdári, Greece
  • Novartis Investigative Site, Larissa, Greece
  • Novartis Investigative Site, Pátrai, Greece
  • Novartis Investigative Site, Thessaloniki, Greece
  • Novartis Investigative Site, Haifa, Israel
  • Novartis Investigative Site, Jerusalem, Israel
  • Novartis Investigative Site, Bologna, BO, Italy
  • Novartis Investigative Site, Florence, FI, Italy
  • Novartis Investigative Site, Genova, GE, Italy
  • Novartis Investigative Site, Milan, MI, Italy
  • Novartis Investigative Site, Palermo, PA, Italy
  • Novartis Investigative Site, Palermo, PA, Italy
  • Novartis Investigative Site, Roma, RM, Italy
  • Novartis Investigative Site, Roma, RM, Italy
  • Novartis Investigative Site, Roma, RM, Italy
  • Novartis Investigative Site, Orbassano, TO, Italy
  • Novartis Investigative Site, Naples, Italy
  • Novartis Investigative Site, Narita, Chiba, Japan
  • Novartis Investigative Site, Sapporo, Hokkaido, Japan
  • Novartis Investigative Site, Nishinomiya, Hyōgo, Japan
  • Novartis Investigative Site, Hanamaki, Iwate, Japan
  • Novartis Investigative Site, Sendai, Miyagi, Japan
  • Novartis Investigative Site, Suita, Osaka, Japan
  • Novartis Investigative Site, Higashi-Matsuyama, Saitama, Japan
  • Novartis Investigative Site, Shinjuku Ku, Tokyo, Japan
  • Novartis Investigative Site, Chiba, Japan
  • Novartis Investigative Site, Fukuoka, Japan
  • Novartis Investigative Site, Fukushima, Japan
  • Novartis Investigative Site, Hiroshima, Japan
  • Novartis Investigative Site, Lublin, Lublin Voivodeship, Poland
  • Novartis Investigative Site, Warsaw, Masovian Voivodeship, Poland
  • Novartis Investigative Site, Krakow, POL, Poland
  • Novartis Investigative Site, Katowice, Silesian Voivodeship, Poland
  • Novartis Investigative Site, Bydgoszcz, Poland
  • Novartis Investigative Site, Katowice, Poland
  • Novartis Investigative Site, Krakow, Poland
  • Novartis Investigative Site, Lublin, Poland
  • Novartis Investigative Site, Poznan, Poland
  • Novartis Investigative Site, Rzeszów, Poland
  • Novartis Investigative Site, Warsaw, Poland
  • Novartis Investigative Site, Lisbon, Portugal
  • Novartis Investigative Site, Lisbon, Portugal
  • Novartis Investigative Site, Porto, Portugal
  • Novartis Investigative Site, Vila Nova de Gaia, Portugal
  • Novartis Investigative Site, Belgrade, Serbia
  • Novartis Investigative Site, Niš, Serbia
  • Novartis Investigative Site, Daegu, South Korea
  • Novartis Investigative Site, Gwangju, South Korea
  • Novartis Investigative Site, Seoul, South Korea
  • Novartis Investigative Site, Seoul, South Korea
  • Novartis Investigative Site, Santiago Compostela, A Coruna, Spain
  • Novartis Investigative Site, L'Hospitalet de Llobregat, Barcelona, Spain
  • Novartis Investigative Site, Alicante, Spain
  • Novartis Investigative Site, Barcelona, Spain
  • Novartis Investigative Site, Lleida, Spain
  • Novartis Investigative Site, Madrid, Spain
  • Novartis Investigative Site, Málaga, Spain
  • Novartis Investigative Site, Valencia, Spain
  • Novartis Investigative Site, Inverness, Invernesshire, United Kingdom
  • Novartis Investigative Site, Ilford, London, United Kingdom
  • Novartis Investigative Site, Swinton, Manchester, United Kingdom
  • Novartis Investigative Site, Birmingham, West Midlands, United Kingdom
  • Novartis Investigative Site, Liverpool, United Kingdom
  • Novartis Investigative Site, London, United Kingdom
  • Novartis Investigative Site, Southampton, United Kingdom
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)